Parapneumonic effusion and thoracic empyema in adults. Clinical aspects, microbiology and frequency of surgical outcome.

BACKGROUND: To date, information about the outcome of patients with parapneumonic effusion and empyema is limited. OBJECTIVE: To describe the clinical characteristics, the microbiological study and the frequency and type of surgical treatment in adult patients with parapneumonic effusion or empyema. METHOD: A prospective cross-sectional study of patients admitted with parapneumonic effusion or empyema, from August 2011 to July 2014, in a reference hospital for respiratory diseases in Mexico City, was conducted. Clinical characteristics, microbiology, risk categories for poor prognosis in empyema and frequency and type of surgical treatment were studied. RESULTS: We studied 284 patients whose median age was 47 years, 75% were men, and 57.7% were transferred from other hospitals. In 38.5% of the cases a microorganism was identified and there was a predominance of Gram negative. 153 (53.9%) required surgical treatment, of which 90% were thoracotomy with decortication. Hospital mortality was 5.63%. CONCLUSIONS: Most of the patients arrived in advanced stages of the disease, so more than half required surgery, of which 90% was decortication. It is desirable to favor mechanisms for early diagnosis and treatment to reduce the need for surgical treatment.

ANTECEDENTES: La información sobre el tipo y la frecuencia del tratamiento quirúrgico en los casos de empiema torácico es escasa. OBJETIVO: Describir las características clínicas, el estudio microbiológico y la frecuencia y el tipo de tratamiento quirúrgico en pacientes adultos con derrame pleural paraneumónico o empiema. MÉTODO: Estudio transversal prospectivo de pacientes con diagnóstico de derrame pleural paraneumónico o empiema, de agosto de 2011 a julio de 2014, en un hospital de referencia para enfermedades respiratorias en la Ciudad de México. Se estudiaron las características clínicas, las categorías de riesgo para mal pronóstico en empiema y la frecuencia y el tipo de tratamiento quirúrgico. RESULTADOS: Se estudiaron 284 pacientes cuya mediana de edad fue de 47 años y el 75% eran hombres. El 57.7% fueron traslados de otros hospitales. En el 38.8% de los casos se identificó un microorganismo, con predominio de gramnegativos. Requirieron tratamiento quirúrgico 153 pacientes (53.9%), de los cuales en el 90% fue toracotomía con lavado y decorticación. La mortalidad hospitalaria fue del 5.63%. CONCLUSIONES: La mayor parte de los pacientes llegaron en etapas avanzadas de la enfermedad, y por ello más de la mitad requirieron cirugía, de los cuales en el 90% fue lavado y decorticación. Es deseable favorecer mecanismos para realizar un diagnóstico y un tratamiento tempranos con el fin de disminuir la necesidad de tratamiento quirúrgico.

The Low-Cost, Long-Term Indwelling Pleural Catheter (LunGO): An Inexpensive and Effective Alternative for the Management of Dyspnea Associated with Malignant Pleural Effusions.

BACKGROUND: A malignant pleural effusion (MPE) in patients with cancer is evidence of the underlying disease progression, resulting in many symptoms, and may lead to hospitalization. The treatment options include talc pleurodesis (TP) or the implantation of an indwelling pleural catheter. The costs of the latter approach are often seen to be inhibitive for the Brazilian and other emerging markets' public health system. OBJECTIVES: To assess the feasibility of utilizing a low-cost device (LunGO) through a case-control study. METHODS: Eighteen patients with recurrent neoplastic pleural effusion and contraindications to pleurodesis were recruited between June 2016 and November 2017. The patients were submitted to pleural catheter prototype implantation. Data on the underlying disease and hospital length of stay after the procedure were collected and compared with patients who underwent pleurodesis in the same period (control group, n = 34). RESULTS: In the LunGO group, 7 patients died due to the natural evolution of the underlying disease with the drain, whereas it was removed in 11 patients at a median of 43 days. Recurrence requiring an intervention was seen with the LunGO in 2, compared to 5 (OR = 1.37, p = 1) with TP. Complications were observed in only 1 with the LunGO, compared to 5 with TP. The chances of recurrence in both cohorts do not have a statistically significant difference, with an OR = 1.08 (p = 0.93). There was a tendency towards lower mortality in the LunGO cohort, despite that fact that we did not observe statistical significance (OR = 0.16, p = 0.23). CONCLUSION: LunGO was shown to be a viable and safe device for the treatment of symptomatic MPE.

Trends in Hospital Treatment of Empyema in Children in the United States.

OBJECTIVE: To evaluate trends in procedures used to treat children hospitalized in the US with empyema during a period that included the release of guidelines endorsing chest tube placement as an acceptable first-line alternative to video-assisted thoracoscopic surgery. STUDY DESIGN: We used National Inpatient Samples to describe empyema-related discharges of children ages 0-17 years during 2008-2014. We evaluated trends using inverse variance weighted linear regression and characterized treatment failure using multivariable logistic regression to identify factors associated with having more than 1 procedure. RESULTS: Empyema-related discharges declined from 3 in 100 000 children to 2 in 100 000 during 2008-2014 (P = .04, linear trend). There was no significant change in the proportion of discharges having 1 procedure (66.1% to 64.1%) or in the proportion having 2 or more procedures (22.1% to 21.6%). The proportion coded for video-assisted thoracoscopic surgery as the only procedure declined (41.4% to 36.2%; P = .03), and the proportions coded for 1 chest tube (14.6% to 20.9%; P = .04) and 2 chest tube procedures (0.9% to 3.5%; P < .01) both increased. The median length of stay for empyema-related discharges remained unchanged (9.3 days to 9.8 days; P = .053). Having more than 1 procedure was associated with continuous mechanical ventilation (adjusted OR, 2.7; 95% CI, 1.8-4.1) but not with age, sex, payer, chronic conditions, transfer admission, hospital size, or census region. CONCLUSIONS: The use of video-assisted thoracoscopic surgery to treat children in the US hospitalized with empyema seems to be decreasing without associated increases in length of stay or need for additional drainage procedures.

Rapid Decrease in Rates of Hospitalization Resulting From Invasive Pneumococcal Disease and Community-Acquired Pneumonia in Children Aged <60 Months After 13-Valent Pneumococcal Conjugate Vaccine Introduction in Argentina.

BACKGROUND: In January 2012, Argentina included universal pneumococcal vaccination in the routine childhood vaccination program using a 13-valent pneumococcal conjugate vaccine (PCV13). A 2 + 1 schedule (2 doses in the first year of life and a booster dose at 12 months of age) in children aged <2 years and 2-dose catch-up immunization in children aged 13 to 24 months was administered during the first year of vaccine introduction. The purpose of this study was to assess the burdens of invasive pneumococcal disease (IPD) and/or community-acquired pneumonia (CAP) in hospitalized children younger than 5 years during the first 2 years of the program compared to those in the prevaccination period in our setting. METHODS: This was a multicenter, prospective, and descriptive study. Rates of hospitalization resulting from IPD and/or CAP in 5 pediatric reference centers across the country were analyzed (every 10 000 admissions). Clinical, epidemiologic, and microbiological data were recorded. Statistical analysis using Stata 8.0 was performed. RESULTS: A comparison of rates of hospitalization resulting from global IPD and/or CAP in the prevaccine (2009-2011) and postvaccine (2012-2013) periods revealed significant decreases of 50% (P = .003) and 51% (P < .0001), respectively. Significant decreases were also observed in number of hospitalizations resulting from empyema (39%; P = .03) and pneumococcal empyema (67.8%; P = .007); the reduction was not statistically significant for pneumococcal CAP (58%; P = .18). Hospital stays for IPD and/or CAP decreased by 56%. CONCLUSION: Rapid and significant decreases in the rates of hospitalization resulting from IPD and/or CAP during the first 2 years after PCV13 introduction were observed. A longer surveillance period is required to confirm these results and the effectiveness of the vaccination program.

Características del empiema paraneumónico luego del inicio de la vacunación antineumocócica. Centro Hospitalario Pereira Rossell, año 2010 / Features of parapneumonic empyema after the beginning of pneumococcal vaccination. CHPR, 2010

El empiema paraneumónico (EP) es complicación grave y frecuente de neumonía adquirida en la comunidad (NAC), causado principalmente por Streptococcus pneumoniae. En Uruguay desde 2008 se incorporaron vacunas conjugadas neumocócicas (PCV), que determinaron disminución en la prevalencia de la enfermedad neumocócica y cambios en los serotipos involucrados. Se realizó un estudio descriptivo para evaluar las características de niños menores de 14 años hospitalizados por EP en el año 2010. Fueron identificados 69 pacientes, que representaron una tasa de 63.4/10.000 egresos. El promedio de edad fue 4 años; 37% de los menores de 5 años tenía 3 dosis de PCV. La presentación inicial fue grave, con 30% de casos que requirieron ingreso a terapia intensiva. El tratamiento recibido fue drenaje toráxico en 96%, instilación de estreptoquinasa intrapleural en 64% y cirugía en 6%. La duración de la hospitalización tuvo un promedio de 18 días. Un porcentaje importante de niños presentó complicaciones; uno falleció. Se identificó germen en 62% de los pacientes, la gran mayoría S. pneumoniae. Los serotipos fueron similares a los identificados antes de la implementación de PCV. No se identificaron fallas vacunales. El EP persiste como enfermedad grave, aunque tras la implementación de PCV disminuyó su prevalencia. No hubo cambios significativos en los serotipos. Es importante continuar la vigilancia del efecto de la implementación de PCV sobre esta patología

Empiema pleural en 343 casos con tratamiento quirúrgico: características, resultados inmediatos y factores asociados a morbilidad y mortalidad / Pleural empyema: retrospective review of 343 patients

Background: Pleural empyema still has a dismal prognosis. Aim: To describe features and prognostic factors of patients with pleural empyema subjected to surgical procedures. Material and Methods: Retrospective review of 343 patients with pleural empyema (mean age 52 years, 71 percent males), that were subjected to any type of surgical procedure. Criteria for diagnosis of empyema were a positive culture, a fluid pH of less than 7.2 or a compatible macroscopic appearance of the fluid. Results: Empyema was secondary to pneumonia in 243 patients (71 percent, secondary to surgical procedures in 41 patients (12 percent), secondary to trauma in 19 patients (5.5 percent), secondary to a lung abscess in 10 patients (3 percent), tuberculous in 10 patients (3 percent), neoplastic in two cases (0.6 percent), secondary to pneumothorax in 2 cases (0.6 percent) and of unknown origin in 13 patients (4 percent). A microorganism was isolated from pleural fluid in 89 patients (26 percent). The surgical procedures performed were 251 decortications by thoracotomy (73 percent), 70 pleurotomies (20 percent), 11 video assisted surgeries (3 percent), seven decortications with lung resections and four fenestrations. Complications were recorded in 104 patients (30 percent), 29 patients were re-operated (8.5 percent) and 31 died (10 percent), all due to sepsis. Conclusions: The main cause of pleural empyema is pneumonia. In most patients, microorganisms are not isolated from pleural fluid, thoracotomy with decortication is the most frequent surgical procedure. There is a high rate of complications and mortality.

Objetivos: Describir características, resultados inmediatos y evaluar factores asociados a morbi-mortalidad de Empiema Pleural (EP) con tratamiento quirúrgico. Método: Revisión retrospectiva. Período: enero 2000 - agosto 2006. Se describen características, resultados inmediatos y factores asociados a morbi-mortalidad. Se utilizó programa SPSS 15.0. Se consideró significativo p < 0,05. Resultados: 343 pacientes, 243 (70,8 por ciento) hombres (relación 2,4:1), edad promedio 51,7 años. Etiología: 242 (70,6 por ciento) paraneumónico, 41 (12,0 por ciento) postquirúrgico, 19 (5,5 por ciento) postraumático, 10 (2,9 por ciento) absceso pulmonar, 10 (2,9 por ciento) tuberculoso, 6 (1,7 por ciento) neoplásico, 2 (0,6 por ciento) neumotórax y 13 (3,8 por ciento) desconocido. Se aisló germen en líquido pleural en 89 (25,9 por ciento). Se realizaron: 251 (73,2 por ciento) decorticaciones por toracotomía, 70 (20,4 por ciento) pleurotomías, 11 (3,2 por ciento) cirugías video-asistidas, 7 (2,1 por ciento) decorticaciones con resección pulmonar y 4 (1,2 por ciento) fenestraciones. Presentaron complicaciones 104 (30,3 por ciento) pacientes. Se reoperaron 29 (8,5 por ciento). Fallecieron 31 (9,6 por ciento), todos por sepsis. Se encontraron variables asociadas a morbi-mortalidad. Conclusiones: El EP tiene como causa más frecuente el empiema paraneumónico seguido de los postoperatorios, en la mayoría no se identifican gérmenes en líquido pleural. La toracotomía con decorticación es el procedimiento quirúrgico más frecuente. El EP tiene una considerable morbi-mortalidad. Se identifican variables asociadas a morbilidad y mortalidad.

Pleural infection: changing bacteriology and its implications.

The incidence of pleural infection continues to rise worldwide. Identifying the causative organism(s) is important to guide antimicrobial therapy. The bacteriology of pleural infection is complex and has changed over time. Recent data suggest that the bacterial causes of empyema are significantly different between adult and paediatric patients, between community-acquired and nosocomial empyemas and can vary among geographical regions of the world. Since the introduction of pneumococcal vaccines, a change has been observed in the distribution of the serotypes of Streptococcus pneumoniae in empyema. These observations have implications on therapy and vaccine strategies. Clinicians need to be aware of the local bacteriology of empyema in order to guide antibiotic treatment.

Clinical profile of pleural empyema and associated factors with prolonged hospitalization in paediatric tertiary centre in Angola, Luanda.

In a case series of 152 children aged from 2 to 132 months will pleural emphema from a paediatric tertiary hospital in Luanda, Angola between September 2004 and March 2005, the authors found a high prevalence of anaemia and malnutrition. The most prevalent bacteria in pleural fluid were: D pneumoniae, Haemophyllus and S aureus. The median for hospital stay was 25 days. The lethality was 7.8% and was not statistically associated with malnutrition, although this variable was associated, in multivariate analysis, with prolonged hospitalization time.

Empiema y efusión pleural en niños / Empyema and pleural efussion in children

Introducción: El empiema pleural (EP) es una complicación grave de la neumonía adquirida en la comunidad (NAC). Objetivos: Describir las características de los pacientes hospitalizados por EP en el Servicio de Pediatría del Hospital de la Universidad Católica durante el período 2000-2005. Se identificaron 86 hospitalizaciones por NAC con efusión pleural, practicándose en 59 (70 por ciento), al menos una toracocentesis. Se consideró EP a la presencia de pus, tinción de Gram con bacterias, cultivo positivo o pH < 7,10 en el líquido pleural, siendo las efusiones para-neumónicas los controles. Resultados: Se analizaron 24 EP y 25 controles [promedio 2,9 años (rango: 8 meses - 14,3 años)], 78 por ciento de edad inferior a 5 años con diferencia entre los grupos EP y controles [1,6 vs 3,3 años, respectivamente (p = 0,01)]. El promedio global (días) de síntomas previo al ingreso en los EP fue 7 (rango: 2-21), siendo los más frecuentes fiebre (100 por ciento) y tos (96 por ciento). Se identificó algún microorganismo en 15/24 EP, Streptococcus pneumoniae fue el más frecuente (n: 9). En 48 niños, el manejo inicial fue conservador, requiriéndose cuatro rescates quirúrgicos luego del cuarto día. El promedio (días) de hospitalización fue significativamente superior en el grupo EP vs controles [15 (rango: 5-38) vs 9 (rango: 3-16) (p < 0,01)]. Requirieron drenaje pleural 83 por ciento del grupo EP y 36 por ciento de los controles (p = 0,002). No hubo diferencia en el número de días de empleo de oxígeno [6 vs 4,5 (p = 0,36)] o drenaje pleural [3 vs 2,5 (p = 0,29)]. No se registraron fallecidos. Conclusión: El EP en niños fue una condición respiratoria aguda que se asoció a estadías hospitalarias prolongadas, especialmente en los de menor edad, no requiriéndose, en la mayoría, una intervención quirúrgica de rescate.

Introduction: Pleural empyema (PE) is a serious complication of community-acquired pneumonia (CAP). Objectives: To describe the clinical profile of hospitalized patients with PE in the pediatric ward of the Catholic University Hospital between 2000-2005. Patients y methods: Retrospectively, all pediatric admission due to CAP and pleural effusion (86 children) were identified. In 59 (70 percent) children > 1 thoracocentesis were performed. We considered PE as the presence in the pleural effusion of pus, and/or a positive gram strain and/ or positive culture, and/or a pH < 7.10. Children with effusions not meeting any criteria were used as controls. Results: Twenty four PE and 25 controls were identified, with a global mean age of 2.9 years (range: 8 months to 14.3 years); 78 percent were < 5 years, with a significant difference between PE and controls [1.6 vs 3.3 years (p = 0.01)]. The mean duration of symptoms in PE patients before admission was 7 days (range: 2-21), and the most frequent symptoms were fever (100 percent) and cough (96 percent). In 15/24 cases a microorganism was identified being Streptococcus pneumoniae (n = 9) the most common. In 48 patients management was conservative and in 4 surgical procedures were required. The mean duration of hospitalization was significantly higher in the PE group vs controls group: 15 (range: 5-38) vs 9 days (range 3-16) (p < 0.01). A chest tube was inserted in 83 percent of children with EP compared with 36 percent in the control group (p = 0.002). There were no difference in number of days of oxygen use [6 vs 4.5 (p = 0.36)] or number of chest tubes per child [3 vs 2.5 (p = 0.29)]. No deaths were reported. Conclusion: PE in children represented an acute respiratory event associated with more prolonged hospitalization especially at younger ages; the majority of cases did not require surgical intervention.

Empiema pleural no tuberculoso: resultados en el Hospital Abel Santamaría Cuadrado (2000 a 2004) / Empiema non tuberculous pleural: results in the Hospital Abel Squared Santamaría (2000 at 2004)

El empiema pleural es una enfermedad infecciosa de incidencia moderada en nuestro medio, de diagnóstico fácil y de tratamiento exitoso cuando se logra descubrir a tiempo. Sin embargo, su persistencia determina la aparición de secuelas con impacto importante en la morbilidad y mortalidad del paciente. Realizamos un estudio retrospectivo, transversal y descriptivo en el que se hace una evaluación del tratamiento de los pacientes con empiema pleural no tuberculoso tratados en el Servicio de Cirugía General del Hospital Abel Santamaría Cuadrado entre enero de 2000 y diciembre de 2004. En una muestra de 34 pacientes fueron estudiadas las variables: edad, sexo, causa, gérmenes, tratamiento adoptado. Se observó que el grupo de edad más afectado fue el de 41 a 60 años (17 pacientes; 50 por ciento) y sobre todo, los pacientes del sexo masculino (82,4 por ciento), con una relación de 3,8:1. En el 61,8 por ciento de los pacientes se encontraron enfermedades pulmonares asociadas y los gérmenes patógenos más frecuentes fueron el Staphylococcus aureus (29,4 por ciento) y el Streptococcus pneumoniae(20,6 por ciento). El mayor porcentaje de los casos fue resuelto mediante cirugía torácica videoasistida (32,4 por ciento). La mayoría de los pacientes llegó a los servicios quirúrgicos en las fases avanzadas de la afección y se apreció un incremento de los cultivos mixtos de gérmenes patógenos. El tratamiento más agresivo de las colecciones purulentas fue el de mejor resultado(AU)

The empiema pleural is an infectious illness of incidence moderated in our means, of easy diagnosis and of successful treatment when it is possible to discover on time. However, their persistence determines the appearance of sequels with important impact in the morbilidad and the patient's mortality. We carry out a retrospective, traverse and descriptive study in which one makes an evaluation of the treatment of the patients with empiema pleural non tuberculous treaties in the Service of General Surgery of the Hospital Abel Squared Santamaría between January of 2000 and December of 2004. In a sample of 34 patients the variables were studied: age, sex, causes, germs, adopted treatment. It was observed that the affected age group went the one from 41 to 60 years (17 patients; 50 percent) and mainly, the patients of the masculine sex (82,4 percent), with a relationship of 3,8:1. By 61,8 percent of the patients they were associate lung illnesses and the germs more frequent patógenos were the Staphylococcus aureus (29,4 percent) and the Streptococcus pneumoniae(20,6 percent). The biggest percentage in the cases was resolved by means of surgery thoracic videoasistida (32,4 percent). most of the patients arrived to the surgical services in the advanced phases of the affection and an increment of the mixed cultivations of germs patógenos was appreciated. The most aggressive treatment in the collections purulentas was that of better result(AU)

[Empyema and pleural effusion in children]. / Empiema y efusión pleural en niños.

INTRODUCTION: Pleural empyema (PE) is a serious complication of community-acquired pneumonia (CAP). OBJECTIVES: To describe the clinical profile of hospitalized patients with PE in the pediatric ward of the Catholic University Hospital between 2000-2005. PATIENTS AND METHODS: Retrospectively, all pediatric admission due to CAP and pleural effusion (86 children) were identified. In 59 (70%) children > 1 thoracocentesis were performed. We considered PE as the presence in the pleural effusion of pus, and/or a positive gram strain and/ or positive culture, and/or a pH < 7.10. Children with effusions not meeting any criteria were used as controls. RESULTS: Twenty four PE and 25 controls were identified, with a global mean age of 2.9 years (range: 8 months to 14.3 years); 78% were < 5 years, with a significant difference between PE and controls [1.6 vs 3.3 years (p = 0.01)]. The mean duration of symptoms in PE patients before admission was 7 days (range: 2-21), and the most frequent symptoms were fever (100%) and cough (96%). In 15/24 cases a microorganism was identified being Streptococcus pneumoniae (n = 9) the most common. In 48 patients management was conservative and in 4 surgical procedures were required. The mean duration of hospitalization was significantly higher in the PE group vs controls group: 15 (range: 5-38) vs 9 days (range 3-16) (p < 0.01). A chest tube was inserted in 83% of children with EP compared with 36% in the control group (p = 0.002). There were no difference in number of days of oxygen use [6 vs 4.5 (p = 0.36)] or number of chest tubes per child [3 vs 2.5 (p = 0.29)]. No deaths were reported. CONCLUSION: PE in children represented an acute respiratory event associated with more prolonged hospitalization especially at younger ages; the majority of cases did not require surgical intervention.

Complicated pneumonias with empyema and/or pneumatocele in children.

To investigate the incidence, procedure type, characteristics of pleural fluid and pneumatoceles, and evolution of pneumonia complicated with empyema and/or pneumatoceles. Review of 394 pediatric pneumonia in patients at São Paulo State University Hospital during 2 years. We studied those with complications such as pleural effusion and pneumatocele. There were 121 (30.71%) with complications such as pleural effusion and pneumatocele; these were significantly higher in infants. One hundred and six children were needle aspirated, of these 78 underwent drainage, and 15 observation only. From the drained, seven needed thoracotomy or pleurostomy. Fluid was purulent in 50%, and pneumatoceles were seen in 33 cases (8.3%) with spontaneous involution in 28 (85%). Pleural fluid culture was negative in 51% cases; in positive cultures, Streptococcus pneumoniae was the most common agent. Complicated pneumonia incidence was higher in the second year of life and more than 70% occurred before 4 years of age. Closed thoracic drainage was effective in over 90%. Large effusions and mediastinal deviations were submitted to more aggressive procedures. Pneumatoceles predominated in the under 3s and were generally evident in the first chest X-ray. Most cases had spontaneous pneumatocele involution, and in almost half the cases were still present at drain tube removal.

El cambiante perfil del empiema pleural en el hospital universitario / New conditioning factors of pleural empyema in university hospital

Antecedentes: A pesar de que se lo practica desde la antig³edad, el tratamiento quirúrgico del empiema pleural sigue requiriendo periódicas revisiones. En la década pasada la videotoracoscopía se constituyó en eje central de una estrategia terapéutica basada en el establecimiento objetivo de la etapa evolutiva de la enfermedad. Sin embargo, cambios demográficos y epidemiológicos en nuestros enfermos hospitalarios han planteado reparos a este enfoque. Objetivo: Identificación de nuevos factores condicionantes y comunicación de nuestra experiencia inicial con un distinto planteo terapéutico. Lugar de aplicación: Hospital Universitario. Diseño: Retrospectivo, observacional. Población: 104 pacientes con diagnóstico de empiema pleural, excluyendo aquellos con antecedentes de algún procedimiento quirúrgico torácico. Método: Se analizaron agrupados por trienios: edad, factores de comorbilidad cuali y cuantitativos, tipo de neumonía que originó el empiema, necesidad de asistencia respiratoria mecánica y requerimiento de inotrópicos. Resultados: A lo largo de los cinco trienios analizados hubo aumento del promedio de edad, de los factores de comorbilidad asociados y del número de empiemas consecutivos a neumonías intrahospitalarias. Con respecto al tratamiento, disminuyó el número de decorticaciones abiertas y videotoracoscópicas, y aumentó el número de pleurostomías con tubo de avenamiento. Se introdujo el uso de fibrinolíticos. Conclusión: Ante un cambio en la epidemiología del empiema pleural en el Hospital de Clínicas se ha planteado una modificación terapéutica que se evaluará mediante un protocolo prospectivo (AU)